ClouDr Group Partners with JD Health to Expand Online Sales and Services
I'm PortAI, I can summarize articles.
ClouDr Group Ltd. has partnered with JD Health International Inc. to enhance online sales and services for Remifemin® and other P2M pipeline products. This collaboration aims to improve patient access to medications and health management services by utilizing JD Health’s e-commerce platform and ClouDr’s chronic disease management expertise. The partnership is expected to promote high-quality, cost-effective medications to a wider audience.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments